Back
Esquire Financial Holdings Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
74
ESQ
Esquire Financial Holdings
Last Price:
64.16
Seasonality Move:
12.67%
Sell
35
ALNY
Alnylam Pharmaceuticals
Last Price:
275.08
Seasonality Move:
4.48%
Buy
74
Esquire Financial Holdings (ESQ)
is a Buy
Is Esquire Financial Holdings a Buy, Sell or Hold?
- The current Esquire Financial Holdings [ESQ] share price is $64.38. The Score for ESQ is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- ESQ is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $274.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ESQ Stock Price Chart
What is Esquire Financial Holdings's stock price today?
-
The Esquire Financial Holdings share price today is $64.38
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESQ is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $274.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.
ESQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.47 | Buy |
Relative Strength Index (14 RSI): | 66.55 | Buy |
Chaikin Money Flow: | 14479 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (60 - 63.16) | Buy |
Bollinger Bands (100): | (47.35 - 60.11) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.58 | Buy |
Relative Strength Index (14 RSI): | 58.54 | Buy |
Chaikin Money Flow: | 227264 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (257.28 - 277.8) | Buy |
Bollinger Bands (100): | (173.47 - 275.75) | Buy |
ESQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 63.58 | Buy |
20-day SMA: | 61.77 | Buy |
50-day SMA: | 59.51 | Buy |
200-day SMA: | 51.09 | Buy |
8-day EMA: | 63.32 | Buy |
20-day EMA: | 62.02 | Buy |
50-day EMA: | 59.07 | Buy |
200-day EMA: | 52.28 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 273.53 | Buy |
20-day SMA: | 264.94 | Buy |
50-day SMA: | 262.48 | Buy |
200-day SMA: | 194.67 | Buy |
8-day EMA: | 272.54 | Buy |
20-day EMA: | 269.21 | Buy |
50-day EMA: | 257.72 | Buy |
200-day EMA: | 211.82 | Buy |
Esquire Financial Holdings Earnings Growth & ESQ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.10 per share, an increase this year of $0.57 per share, and an increase next year of $0.43 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.
Esquire Financial Holdings Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |